ALKYLAMINE — Alkyl Amines Chemicals Balance Sheet
0.000.00%
- IN₹92.48bn
- IN₹91.14bn
- IN₹14.41bn
- 99
- 10
- 64
- 63
Annual balance sheet for Alkyl Amines Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | — | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 312 | 1,552 | 615 | 172 | 304 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,669 | 2,463 | 3,054 | 2,886 | 2,308 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,941 | 5,279 | 5,376 | 5,006 | 4,434 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,668 | 5,945 | 7,698 | 10,676 | 11,211 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 7,834 | 11,453 | 13,713 | 15,919 | 15,836 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,538 | 2,818 | 3,279 | 3,542 | 2,279 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,468 | 3,529 | 3,815 | 4,230 | 3,165 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 5,366 | 7,925 | 9,898 | 11,689 | 12,671 |
Total Liabilities & Shareholders' Equity | 7,834 | 11,453 | 13,713 | 15,919 | 15,836 |
Total Common Shares Outstanding |